Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 8 studies | 25% ± 8% | |
oligodendrocyte precursor cell | 7 studies | 34% ± 13% | |
retinal cone cell | 6 studies | 23% ± 6% | |
macrophage | 4 studies | 16% ± 1% | |
endothelial cell | 3 studies | 20% ± 1% | |
GABAergic neuron | 3 studies | 24% ± 4% | |
glutamatergic neuron | 3 studies | 31% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 30% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 3050.41 | 2642 / 2642 | 100% | 53.98 | 703 / 705 |
thymus | 100% | 7677.37 | 653 / 653 | 99% | 58.75 | 600 / 605 |
lung | 100% | 2179.80 | 576 / 578 | 99% | 22.04 | 1146 / 1155 |
breast | 100% | 1911.48 | 459 / 459 | 99% | 29.74 | 1103 / 1118 |
prostate | 100% | 1974.88 | 244 / 245 | 98% | 28.90 | 493 / 502 |
stomach | 100% | 1703.48 | 359 / 359 | 98% | 21.31 | 279 / 286 |
intestine | 100% | 1471.29 | 965 / 966 | 97% | 20.11 | 511 / 527 |
adrenal gland | 100% | 4497.01 | 258 / 258 | 97% | 30.40 | 222 / 230 |
pancreas | 99% | 1287.97 | 325 / 328 | 97% | 19.51 | 173 / 178 |
kidney | 100% | 1851.43 | 89 / 89 | 96% | 23.38 | 866 / 901 |
esophagus | 98% | 1485.46 | 1418 / 1445 | 98% | 22.43 | 179 / 183 |
ovary | 100% | 1471.24 | 180 / 180 | 95% | 15.48 | 407 / 430 |
bladder | 100% | 1654.14 | 21 / 21 | 93% | 18.81 | 467 / 504 |
skin | 100% | 1678.79 | 1802 / 1809 | 93% | 27.02 | 438 / 472 |
uterus | 100% | 2636.35 | 170 / 170 | 92% | 19.66 | 423 / 459 |
liver | 92% | 768.54 | 207 / 226 | 69% | 9.73 | 281 / 406 |
adipose | 100% | 1784.03 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 2189.15 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1756.47 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 1393.05 | 829 / 861 | 0% | 0 | 0 / 0 |
muscle | 96% | 845.19 | 773 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 16.35 | 40 / 45 |
lymph node | 0% | 0 | 0 / 0 | 83% | 16.18 | 24 / 29 |
peripheral blood | 66% | 821.26 | 616 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 55% | 8.28 | 44 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006325 | Biological process | chromatin organization |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
Gene name | RCBTB1 |
Protein name | RCC1 and BTB domain-containing protein 1 (Chronic lymphocytic leukemia deletion region gene 7 protein) (CLL deletion region gene 7 protein) (Regulator of chromosome condensation and BTB domain-containing protein 1) |
Synonyms | E4.5 CLLD7 |
Description | FUNCTION: May be involved in cell cycle regulation by chromatin remodeling. . |
Accessions | ENST00000378302.7 [Q8NDN9-1] Q8NDN9 ENST00000258646.3 [Q8NDN9-1] |